The optimized anticoagulation strategy in prolonged hemodialysis.
Raïsa ThielemansFloris VanommeslaegheIván JosipovicFilip De SomerKatrien M J DevreeseMatthieu N BooneWim Van BiesenSunny ElootPublished in: Clinical kidney journal (2023)
Our results indicate that there is no need to administer enoxaparin over two injections for ENHD up to 8 h. The usefulness of monitoring anti-Xa levels to predict fiber patency, assessed by µCT, can be questioned, but further clinical trials are needed.
Keyphrases
- venous thromboembolism
- clinical trial
- image quality
- dual energy
- computed tomography
- peritoneal dialysis
- end stage renal disease
- atrial fibrillation
- contrast enhanced
- chronic kidney disease
- ultrasound guided
- platelet rich plasma
- positron emission tomography
- phase ii
- magnetic resonance imaging
- study protocol
- phase iii